US Patent 11273159 Pharmaceutical formulations
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Cheryl A. Grice0
Hibreniguss Terefe0
Isaac Ghebre-Sellassie0
Joel P. Zingerman0
Nicole S. White0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
112731590
Date of Patent
March 15, 2022
0Patent Application Number
163490420
Date Filed
November 15, 2017
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 3 Apr, 2023
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 22 Sep, 2022
Golden AI
Infobox
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Mar, 2022
Golden AI
Edits made to:
Infobox (+5 properties)
Article (+205 characters)
Article
Provided herein are pharmaceutical formulations comprising a monoacylglycerol lipase (MAGL) inhibitor, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient.
Infobox
Edits on 16 Mar, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11273159 Pharmaceutical formulations
Infobox
Is a
Patent jurisdiction
Patent number
11273159
Date of patent
March 15, 2022
Patent application number
16349042
Date Filed
November 15, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11273159 Pharmaceutical formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
